Dr. Sangeetha Merrin Varghese Bags International Recognition: A Moment of Pride for BCMCH!

 Dr. Sangeetha Merrin Varghese Bags International Recognition: A Moment of Pride for BCMCH!



A resounding applause for Dr. Sangeetha Merrin Varghese, who has been conferred with the prestigious International Outstanding Researcher Award at the 2024 International Congress for Research Excellence! This remarkable achievement is a testament to her unwavering dedication and invaluable contributions to the field.

The International Congress for Research Excellence is a premier platform that brings together the brightest minds from across the globe. To be recognized for outstanding research at such a forum is a significant feat, and we at BCMCH are incredibly proud of Dr. Varghese's accomplishment.

Dr. Varghese's research has undoubtedly played a pivotal role in [mention the field of research]. Her work has not only expanded our understanding of [mention the specific area of research] but has also paved the way for [mention the potential impact of her research].

Her dedication goes beyond the realm of research. We at BCMCH are fortunate to have Dr. Varghese as part of our esteemed faculty, inspiring not just her peers but also generations of future researchers. Her passion for knowledge and commitment to excellence are truly infectious.

This award is not just a recognition of Dr. Varghese's past achievements but also a stepping stone to even greater feats in the times to come. We, at BCMCH, extend our heartfelt congratulations to Dr. Varghese and offer our unwavering support for her future endeavors. We are confident that she will continue to make groundbreaking contributions and bring immense pride to our institution.

Let's shower Dr. Varghese with congratulatory messages in the comments below!





Comments

Be Connected

Introducing Prof. Dr. Sumith K. Mathew: A Pioneer in Precision Medicine, Therapeutic Drug Monitoring, and Pharmacometrics

CIDSCON 2023: A Showcase of Clinical Infectious Diseases Expertise in India

Excellence in Medical Education and Compassionate Patient Care: QUEST Seminar Brain and Behaviour: A No-Brainer?

ISGKCON* (Indian Society of Gastroenterology Kerala Mid Term Conference) held in Kannur!

National Level Scientific Session – “Research to Reality”

Title: Breaking News: National Training Program on Pharmacovigilance to Enhance Drug Safety Introduction: In a significant development, the ADR Monitoring Centre of the Department of Pharmacology at BCMCH (Benedictine College of Medicine and Health Sciences) is conducting a National Training Program under the aegis of the Pharmaco Vigilance Program of India (PVPI). This program aims to educate and empower healthcare professionals to enhance drug safety through effective pharmacovigilance practices. With esteemed speakers and participants from across the country, this training program promises to be a transformative event for the field of pharmacology. Program Details: The National Training Program is scheduled for Friday, the 3rd of May, commencing at 7 PM. The program will feature distinguished speakers who are experts in the field of pharmacovigilance, including Dr. Shwetha Reba Mathews and Dr. Suman Varghese Sam. Dr. Mathews, who was recently appointed as one of the National Pharmacovigilance trainers, brings a wealth of experience and knowledge to the event. Dr. Sam, a renowned psychiatrist, will also be sharing valuable insights on drug safety from a mental health perspective. The program will be moderated by Dr. Jacob Jesurun, the Coordinator of the ADR Monitoring Centre. Importance of Pharmacovigilance: Pharmacovigilance plays a crucial role in ensuring the safety and well-being of patients. It involves the monitoring, detection, assessment, and prevention of adverse drug reactions (ADRs). By systematically collecting and analyzing data on drug safety, healthcare professionals can identify potential risks associated with medications and take appropriate measures to minimize harm. The National Training Program aims to foster a culture of pharmacovigilance across the country, ultimately leading to improved patient outcomes. Impact on Patient Safety: The primary objective of this training program is to equip healthcare professionals with the necessary skills and knowledge to identify and report adverse drug reactions effectively. By raising awareness about the importance of pharmacovigilance, the program seeks to enhance patient safety. Participants attending the program will gain a deeper understanding of the significance of adverse drug reaction monitoring and reporting, enabling them to contribute to a safer healthcare environment. National Reach: The National Training Program has attracted participants from all corners of the country. This diverse group of healthcare professionals represents various fields, including pharmacology, medicine, nursing, and pharmacy. The program's national scope reflects the growing recognition of the importance of pharmacovigilance in India and the commitment of healthcare professionals to ensuring the safe use of medications. Conclusion: As the National Training Program on Pharmacovigilance approaches, the Department of Pharmacology at BCMCH is poised to deliver an impactful and meaningful session. With esteemed speakers, expert moderation, and participants from across the country, this program promises to be a transformative event in the field of drug safety. By equipping healthcare professionals with the necessary knowledge and skills, the program aims to improve patient outcomes and contribute to a safer and more informed healthcare system. The efforts of the department and the participants in attending this training program are commendable, and their commitment to drug safety is an inspiration for the entire medical community.

Breaking News: Believers ED Presents Be-APT for MRCEM OSCE Preparation

RACTHAM Team Shines at the 64th Annual Conference of Indian Society of Haematology and Blood Transfusion (ISHBT)

Dr. Arunima Poulose Triumphs at ASOMA Conference: Unveiling the "Surprise" In-Situ : quest

Successful Inauguration of HERNIA-CME 2024